Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody
- PMID: 16862157
- DOI: 10.1038/nsmb1127
Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody
Abstract
Elicitation of potent and broadly neutralizing antibodies is an important goal in designing an effective human immunodeficiency virus-1 (HIV-1) vaccine. The HIV-1 gp41 inner-core trimer represents a functionally and structurally conserved target for therapeutics. Here we report the 2.0-A-resolution crystal structure of the complex between the antigen-binding fragment of D5, an HIV-1 cross-neutralizing antibody, and 5-helix, a gp41 inner-core mimetic. Both binding and neutralization depend on residues in the D5 CDR H2 loop protruding into the conserved gp41 hydrophobic pocket, as well as a large pocket in D5 surrounding core gp41 residues. Kinetic analysis of D5 mutants with perturbed D5-gp41 interactions suggests that D5 persistence at the fusion intermediate is crucial for neutralization. Thus, our data validate the gp41 N-peptide trimer fusion intermediate as a target for neutralizing antibodies and provide a template for identification of more potent and broadly neutralizing molecules.
Similar articles
-
Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.J Mol Biol. 2008 Dec 12;384(2):377-92. doi: 10.1016/j.jmb.2008.09.024. Epub 2008 Sep 18. J Mol Biol. 2008. PMID: 18824005
-
Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.J Mol Biol. 2008 Oct 17;382(4):910-9. doi: 10.1016/j.jmb.2008.07.057. Epub 2008 Jul 27. J Mol Biol. 2008. PMID: 18692506
-
Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.Immunity. 2005 Feb;22(2):163-73. doi: 10.1016/j.immuni.2004.12.011. Immunity. 2005. PMID: 15723805
-
The complex antigenicity of a small external region of the C-terminal tail of the HIV-1 gp41 envelope protein: a lesson in epitope analysis.Rev Med Virol. 2005 Nov-Dec;15(6):365-81. doi: 10.1002/rmv.476. Rev Med Virol. 2005. PMID: 16106492 Review.
-
HIV-1 fusion protein exerts complex immunosuppressive effects.Trends Biochem Sci. 2013 Jul;38(7):345-9. doi: 10.1016/j.tibs.2013.04.003. Epub 2013 May 17. Trends Biochem Sci. 2013. PMID: 23685134 Review.
Cited by
-
HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies.Science. 2015 Aug 14;349(6249):aab1253. doi: 10.1126/science.aab1253. Epub 2015 Jul 30. Science. 2015. PMID: 26229114 Free PMC article.
-
Few and far between: how HIV may be evading antibody avidity.PLoS Pathog. 2010 May 27;6(5):e1000908. doi: 10.1371/journal.ppat.1000908. PLoS Pathog. 2010. PMID: 20523901 Free PMC article. No abstract available.
-
The C34 Peptide Fusion Inhibitor Binds to the Six-Helix Bundle Core Domain of HIV-1 gp41 by Displacement of the C-Terminal Helical Repeat Region.Biochemistry. 2015 Nov 17;54(45):6796-805. doi: 10.1021/acs.biochem.5b01021. Epub 2015 Nov 9. Biochemistry. 2015. PMID: 26506247 Free PMC article.
-
A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin.Nat Struct Mol Biol. 2013 Mar;20(3):363-70. doi: 10.1038/nsmb.2500. Epub 2013 Feb 10. Nat Struct Mol Biol. 2013. PMID: 23396351 Free PMC article.
-
Biophysical studies of HIV-1 glycoprotein-41 interactions with peptides and small molecules - Effect of lipids and detergents.Biochim Biophys Acta Gen Subj. 2020 Dec;1864(12):129724. doi: 10.1016/j.bbagen.2020.129724. Epub 2020 Sep 2. Biochim Biophys Acta Gen Subj. 2020. PMID: 32889078 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
